Sweden· SE-20050512000016
Rapydan 70 mg/70 mg Medicinskt plåster
A medicinal product containing lidocaine + tetracaine, registered in Sweden by Eurocept International B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Lidocaine + Tetracaine
- Manufacturer
- Eurocept International B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20050512000016
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lidocaine + tetracaine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyPliaglisCroma Pharma Gmbh
- NetherlandsPliaglis 70 mg/g + 70 mg/g crèmeCroma Pharma GmbH
- CzechiaPLIAGLISEgis Pharmaceuticals PLC, Budapešť
- United KingdomPliaglis 70mg/g / 70mg/g creamCroma-Pharma GmbH
- United StatesBlockaidSofTap Inc
- IrelandPliaglis 70mg/g + 70mg/g creamCroma-Pharma GmbH
- SpainPLIAGLIS 70 MG/G + 70 MG/G CREMAIndustrial Farmaceutica Cantabria S.A.
- CanadaPLIAGLISSCIENCES DE LA PEAU CRESCITA INC. / CRESCITA SKIN SCIENCES INC.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Pliaglis, Rapydan
- Belgium · Pliaglis, Rapydan
- Bulgaria · Плиаглис
- Czechia · Pliaglis
- Germany · Pliaglis, Rapydan
- Denmark · Pliapel, Ralydan
- Spain · Pliaglis
- United Kingdom (Northern Ireland) · Pliaglis, Rapydan
- Greece · Pliaglis
- Hungary · Pliapeel
- Ireland · Pliaglis
- Italy · Pliaglis
- Lithuania · Cessolute
- Luxembourg · Pliaglis, Rapydan
- Latvia · Cessolute
- Netherlands · Pliaglis, Rapydan
- Norway · Pliapel, Rapydan
- Poland · Pliaglis
- Portugal · Pliaglis
- Slovakia · Pliaglis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/684b2508-e0f0-4456-8361-5500de24dcdd GET /v1/drugs/684b2508-e0f0-4456-8361-5500de24dcdd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC",
"PAR"
],
"se_npl_id": "20050512000016",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20050512000016",
"product_doc_link": "https://docetp.mpa.se/LMF/Rapydan%20medicated%20patch%20SmPC_09001bee807a6a53.pdf"
}See everything about lidocaine + tetracaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.